Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Glucose and Acadesine

supplement:

Glucose

Research Papers that Mention the Interaction

administration of AICAR reduces hepatic glucose output, thereby lowering blood glucose concentrations in vivo in type 2 diabetic patients.
Diabetologia  •  2008  |  View Paper
Mean whole-body glucose disposal increased by 7% with AICAR from 9.3 ± 0.6 to 10 ± 0.6 mg · kg−1 · min−1 (P < 0.05).
Diabetes  •  2007  |  View Paper
Collectively, the findings suggest that AICAR acutely promotes muscle glucose uptake in healthy horses and thus its therapeutic potential for managing IR requires investigation.
Veterinary journal  •  2015  |  View Paper
Significance: AICAR is significantly more cytotoxic on glucose and thus potentially targets cells prone to Warburg effect.
The Journal of Biological Chemistry  •  2015  |  View Paper
Plasma [K(+)] and glucose ] both dropped at 1 h of AICAR infusion and [K(+)] dropped to 3.3 +/- 0.04 mM by 3 h, linearly related to the increase in muscle AMPK phosphorylation.
American journal of physiology. Cell physiology  •  2008  |  View Paper
AICAR inhibited ATP-sensitive K(+) (K(ATP)) channels and increased the frequency of glucose-induced calcium oscillations in islets incubated in 8-14 mM glucose.
Biochemical and biophysical research communications  •  2005  |  View Paper
The higher AICAR dose resulted in a profound shift in hepatic glucose balance from net uptake to a marked net output (-6.1 +/- 1.9 mg .
Diabetes  •  2005  |  View Paper
AICAR treatment significantly increased glucose and FA uptake during R (P < 0.05) but had no effect on either variable during ES (P > 0.05).
American journal of physiology. Endocrinology and metabolism  •  2005  |  View Paper
Thus, intraportal AICAR infusion caused marked stimulation of both hepatic glucose output and net hepatic glycogenolysis, even in the presence of high levels of physiological insulin.
Diabetes  •  2005  |  View Paper
AICAR decreased plasma levels of glucose (approximately 25%), insulin (approximately 60%), and FAs (approximately 30%) at various times over the next 46 min (P < 0.05 vs. controls).
Diabetes  •  2004  |  View Paper
Show More